Predict earnings surprises, measure growth across procedures and infusion therapeutics, and track macro utilization trends derived from domestic medical claims. Leo medical claims data is sourced from the largest US healthcare claims clearinghouse.

Analyze complete patient journeys across both medical and pharmacy claims and accurately track metrics like patient persistence, therapy switches, and concomitant therapies. Medical claims data is sourced from a large health service company with visibility into unblinded provider identities and strong longitudinal integrity allowing for accurate patient journey analytics.

This dataset contains data for the Healthcare Payments Data (HPD) Snapshot visualization. The Enrollment data file contains counts of claims and encounter data collected for California's statewide HPD Program. It includes counts of enrollment records, service records from medical and pharmacy claims, and the number of individuals represented across these records. Aggregate counts are grouped by payer type (Commercial, Medi-Cal, or Medicare), product type, and year. The Medical data file contains counts of medical procedures from medical claims and encounter data in HPD. Procedures are categorized using claim line procedure codes and grouped by year, type of setting (e.g., outpatient, laboratory, ambulance), and payer type. The Pharmacy data file contains counts of drug prescriptions from pharmacy claims and encounter data in HPD. Prescriptions are categorized by name and drug class using the reported National Drug Code (NDC) and grouped by year, payer type, and whether the drug dispensed is branded or a generic.

This data package contains claims-based data about beneficiaries of Medicare program services including Inpatient, Outpatient, related to Chronic Conditions, Skilled Nursing Facility, Home Health Agency, Hospice, Carrier, Durable Medical Equipment (DME) and data related to Prescription Drug Events. It is necessary to mention that the values are estimated and counted, by using a random sample of fee-for-service Medicare claims.

Dataset

This dataset was created by Bunty Shah

Contents

The Health Claims Data Warehouse (HCDW) will receive and analyze health claims data to support management and administrative purposes. The Federal Employee Health Benefits Program (FEHBP) is a $40 billion program covering approximately 8 million eligible participants using more than 100 health insurance carriers. The HCDW will incorporate extensive analytical capabilities to support cost analysis, administration, design, and quality improvement of healthcare services provided to eligible participants.

2016-2019. This dataset is a de-identified summary table of prevalence rates for vision and eye health data indicators from the Medicaid Analytic eXtract (MAX) data. Medicaid MAX are a set of de-identified person-level data files with information on Medicaid eligibility, service utilization, diagnoses, and payments. The MAX data contain a convenience sample of claims processed by Medicaid and Children’s Health Insurance Program (CHIP) fee for service and managed care plans. Not all states are included in MAX in all years, and as of November 2019, 2014 data is the latest available. Prevalence estimates are stratified by all available combinations of age group, gender, and state. Detailed information on VEHSS Medicare analyses can be found on the VEHSS Medicaid MAX webpage (cdc.gov/visionhealth/vehss/data/claims/medicaid.html). Information on available Medicare claims data can be found on the ResDac website (www.resdac.org). The VEHSS Medicaid MAX dataset was last updated May 2023.

This dataset tracks the updates made on the dataset "Center for Medicare & Medicaid Services (CMS) , Medicare Claims data" as a repository for previous versions of the data and metadata.

The COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured Program provides reimbursements on a rolling basis directly to eligible health care entities for claims that are attributed to the testing, treatment, and or vaccine administration of COVID-19 for uninsured individuals. The program funding information is as follow:

TESTING The American Rescue Plan Act (ARP) which provided $4.8 billion to reimburse providers for testing the uninsured; the Families First Coronavirus Response Act (FFCRA) Relief Fund, which includes funds received from the Public Health and Social Services Emergency Fund, as appropriated in the FFCRCA (P.L. 116-127) and the Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) (PPPHCEA), which each appropriated $1 billion to reimburse health care entities for conducting COVID-19 testing for the uninsured.

TREATMENT & VACCINATION The Provider Relief Fund, which includes funds received from the Public Health and Social Services Emergency Fund, as appropriated in the Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136), provided $100 billion in relief funds. The PPPHCEA appropriated an additional $75 billion in relief funds and the Coronavirus Response and Relief Supplemental Appropriations (CRRSA) Act (P.L. 116-260) appropriated another $3 billion. Within the Provider Relief Fund, a portion of the funding from these sources will be used to support healthcare-related expenses attributable to the treatment of uninsured individuals with COVID-19 and vaccination of uninsured individuals. To learn more about the program, visit: https://www.hrsa.gov/CovidUninsuredClaim

This dataset represents the list of health care entities who have agreed to the Terms and Conditions and received claims reimbursement for COVID-19 testing of uninsured individuals, vaccine administration and treatment for uninsured individuals with a COVID-19 diagnosis.

For Provider Relief Fund Data - https://data.cdc.gov/Administrative/HHS-Provider-Relief-Fund/kh8y-3es6

CMS Data Feeds includes 119 report feeds, with 25.8B+ rows of data including reporting on claims data dating back to 2007. Updated monthly, this dataset is ideal for tracking healthcare metrics over time, with cleaned and aligned attributes for easy ingestion and comprehensive analysis.

Data provided by insurers, on the premiums written and claims incurred for the 2013 fiscal year. Based on reporting on the consolidated pages of the P&C-1 or Life-1 Annual returns. This data is also reported in the Superintendent of Insurance’s Annual Report.

Track specialty drug utilization, analyze patient journeys, and predict earnings surprises based on domestic pharmacy claims capturing ~ 90 million patients. Pharmacy claims data is sourced from a large health services company with visibility into commonly blocked specialty pharmacy drugs and strong longitudinal integrity allowing for accurate patient journey analytics.

A collection of TSA Claims Data from 2002 to 2017 in the DHS Publication Library.

This dataset is designed to analyze prescription drug use and spending among New York State residents at the drug product level (pharmacy claims data that have been aggregated by labeler code and product code segments of the National Drug Code). The dataset includes the number of prescriptions filled by unique members by payer type, nonproprietary name, labeler name, dosage characteristics, amount insurer paid, and more.

Oregon workers' compensation claims counts. Where available, the data is provided since 1968, the year Oregon's modern workers' compensation system began. The data is presented in the Department of Consumer and Business Services report at https://www.oregon.gov/dcbs/reports/compensation/Pages/index.aspx. The attached pdf provides definitions of the data.

Dataset

This dataset was created by AnkushAgarwal

Contents

Predict earnings surprises, track drug adoption and sales, measure label expansion, and analyze market access based on domestic pharmacy claims. Leo pharmacy claims data is sourced from the largest US healthcare claims clearinghouse.

Analysis of ‘Center for Medicare & Medicaid Services (CMS) , Medicare Claims data’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://catalog.data.gov/dataset/46975378-a51c-42ad-b06e-5aae9db45d16 on 12 February 2022.

--- Dataset description provided by original source is as follows ---

2003 forward. CMS compiles claims data for Medicare and Medicaid patients across a variety of categories and years. This includes Inpatient and Outpatient claims, Master Beneficiary Summary Files, and many other files. Indicators from this data source have been computed by personnel in CDC's Division for Heart Disease and Stroke Prevention (DHDSP). This is one of the datasets provided by the National Cardiovascular Disease Surveillance System. The system is designed to integrate multiple indicators from many data sources to provide a comprehensive picture of the public health burden of CVDs and associated risk factors in the United States. The data are organized by location (national and state) and indicator. The data can be plotted as trends and stratified by sex and race/ethnicity.

--- Original source retains full ownership of the source dataset ---

Marion County is seeking bids for 23P-072 Healthcare Claims Data due 2023-02-23T06:00:00.000Z

Archived as of 6/26/2025: The datasets will no longer receive updates but the historical data will continue to be available for download. This dataset provides information related to access and transportation related claims. It contains information about the total number of patients, total number of claims, and total dollar amount, grouped by provider. Restricted to claims with service date between 01/2012 to 12/2017. Transportation claims identified as billing provider type 26 and related category of service type. This data is for research purposes and is not intended to be used for reporting. Due to differences in geographic aggregation, time period considerations, and units of analysis, these numbers may differ from those reported by FSSA.